Investment by Directors and Management demonstrates confidence in the Company Potential for an additional 1.8millionupontheexerciseinfullofwarrantsBOTHELL,Wash.,Oct.30,2025(GLOBENEWSWIRE)−−CocrystalPharma,Inc.(Nasdaq:COCP)(the“Company”or“Cocrystal”)announcesthecompletionofaprivateplacementofunitspricedat−the−marketunderNasdaqruleswith743,024sharesofitscommonstockatapurchasepriceof1.39 per unit for proceeds of $1.03 million and unregistered warrants to pu ...